Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

AZ and BMS diabetes drug needs more data

January 20, 2012 Research and Development, Sales and Marketing AstraZeneca, BMS, FDA approvals, diabetes

AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …
News

Novartis starts late-stage biosimilar trials for Amgen drugs

January 19, 2012 Research and Development, Sales and Marketing Amgen, Neulasta, Neupogen, Novartis

Novartis has begun Phase III biosimilar trials to copycat two of Amgen’s neutropenia drugs. The studies, which are being undertaken …
News

Chief operating officer appointed to Clinigen’s services division

January 19, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton

Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …
Appointment
Takeda image

Takeda to cut 2,800 jobs

January 19, 2012 Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …
News
mike_crooks_web

Astellas Pharma Europe appoints Mike Crooks to head up its UK operations

January 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …
Appointment
Bayer image

Bayer’s colorectal cancer drug increases survival

January 19, 2012 Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib

Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …
News

Former Bristol-Myers Squibb man becomes head of Savient Europe

January 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Savient

Savient Pharmaceuticals has appointed David Veitch as the new president of its European division. Veitch joins the specialist biopharma firm …
Appointment
Pfizer image

Pfizer pulls plug on Alzheimer’s drug

January 18, 2012 Research and Development, Sales and Marketing Medivation, Pfizer, dimebon

Pfizer and Medivation have written off their Alzheimer’s candidate dimebon after another Phase III failure.  The firms said a 12-month …
News
Novartis image

Novartis reverses plant closure decision

January 18, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Basel, Diovan, Novartis, Nyon, closure, job cuts

Novartis has said it will not close down a plant in Switzerland that had been due for closure, and has …
News
Tamiflu image

BMJ blasts Roche for withholding Tamiflu data

January 18, 2012 Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO

Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …
News

The work of NICE International

January 17, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kalipso Chalkidou, NICE

NICE, or the National Institute for Health and Clinical Excellence, to give it its full title, is world famous for …
Feature

CoreLab Partners opens office in Tokyo, Japan

January 17, 2012 Research and Development

Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and …
News
Press release

Oxford BioTherapeutics appoints C. Glenn Begley as a senior clinical advisor

January 17, 2012 Business Services, Research and Development, Sales and Marketing C. Glenn Begley, Oxford Biotherapeutics

Oxford BioTherapeutics has appointed C. Glenn Begley as a senior clinical advisor and non-executive director of the firm.  Dr Begley, …
Appointment

Contract research news in brief

January 17, 2012 Manufacturing and Production, Research and Development AAIPharma and General Dynamics, Charles River Labs, Covance, ICON, ShangPharma

A round-up of developments in the contract research sector, including updates on Charles River Labs, ShangPharma, Icon, Covance, AAIPharma and …
News

Otsuka and UCB scale down collaboration

January 16, 2012 Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB

Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025